Neutral Lipid Storage Disease With Myopathy - 3 Studies Found
Recruiting |
: Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M :
|
Completed |
: The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM) : Neutral Lipid Storage Disease : 2012-01-16 : Drug: Fibrate treatment Patients will receive a dosage of 400mg Bezafibrate every day during 28 weeks |
Recruiting |
: International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases : Neutral Lipid Storage Disease : 2016-08-04 |